Effect and benefit of percutaneous coronary intervention in chronic total occlusion on ventricular repolarization: QT

Ameen Abdulhasan Al Alwany1

  • 1College of Medicine, University of Baghdad, Baghdad, Iraq.

Insights

Percutaneous coronary intervention (PCI) significantly reduces corrected QT (QTc) dispersion in patients with chronic total coronary artery occlusion. This finding highlights PCI

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Imaging

Background:

  • ST segment, T wave, and QT interval changes are key electrocardiogram (ECG) parameters for diagnosing ischemic heart disease.
  • Elevated QT dispersion, particularly corrected QT (QTc) dispersion, is linked to myocardial ischemia and coronary artery disease (CAD).
  • Chronic total occlusion (CTO) presents a significant challenge in managing coronary artery disease.

Purpose of the Study:

  • To evaluate changes in surface electrocardiography (ECG) parameters, specifically QTc dispersion, following percutaneous coronary intervention (PCI).
  • To assess the impact of PCI on depolarization and repolarization variations in patients with CTO.
  • To determine if PCI revascularization influences QTc dispersion in CTO patients.

Main Methods:

  • A study involving 110 patients with CTO who underwent PCI revascularization at the Iraqi Center for Heart Disease (October 2020 - February 2021).
  • Twelve-lead ECGs were recorded 12 hours before PCI and over one hour after the intervention.
  • Measured parameters included corrected QT (QTc) interval durations and QTc dispersion, comparing pre- and post-PCI values.

Main Results:

  • A statistically significant change was observed in average QTc interval and QTc dispersion before and after PCI.
  • PCI revascularization in patients with CTO resulted in a major reduction in QTc dispersion.
  • The study demonstrated a significant improvement in ECG repolarization parameters post-intervention.

Conclusions:

  • Percutaneous coronary intervention is effective in reducing QTc dispersion in patients suffering from chronic total coronary artery occlusion.
  • The reduction in QTc dispersion post-PCI suggests an improvement in myocardial electrical stability.
  • ECG parameters like QTc dispersion can serve as valuable indicators of treatment efficacy in CTO patients undergoing PCI.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
133
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35